Does first polar body morphology predict oocyte performance during ICSI treatment?
OBJECTIVE
To gain insight into the morphology of the first polar body (1 PB) in ICSI patients and to explore whether it could predict mature oocyte viability and performance in this setting.


METHODS
Seventy two consecutive women planned to perform ICSI treatment were prospectively recruited for this study. All oocytes retrieved underwent evaluation for nuclear maturity and accurate assessment of 1 PB morphology. MII oocytes were cultured in separate groups in each woman in accordance with two different categories of 1 PB morphology. Category A included normal intact round or ovoid 1 PB and category B included abnormal fragmented 1 PB. Each oocyte was followed throughout fertilization, embryo cleavage and embryo transfer. Cycles that reached embryo transfer, were divided into three groups in accordance with 1 PB morphology. Group I included only category A 1 PB embryos, group II included categories A and B 1 PB embryos, whereas group III included only category B 1 PB embryos.


RESULTS
A total of 687 oocytes were aspirated and 553 MII oocytes underwent ICSI leading to 410 zygotes showing normal fertilization on day one. Three hundred ninety seven embryos cleaved on day two and a total of 176 embryos were replaced into the uterus. Clinical implantation and pregnancy rates were significantly correlated with the morphology of the 1 PB corresponding to 31%, 9% and 2% and 61%, 24% and 5%, in groups I, II and III respectively.


CONCLUSIONS
Our findings demonstrate that 1 PB morphology is related to mature oocyte viability and it has the potential to predict oocyte performance and pregnancy achievement in infertile women undergoing ICSI treatment.
Younis
Johnny S
JS
Reproductive Medicine Unit, Department of Obstetrics & Gynecology, Poriya Medical Center, Tiberias 15208, Israel. jsy@netvision.net.il
Radin
Orit
O
Izhaki
Ido
I
Ben-Ami
Moshe
M
D004624:Embryo Transfer; D047108:Embryonic Development / Q000502:physiology*; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D006801:Humans; D016015:Logistic Models; D007986:Luteinizing Hormone / Q000097:blood; D008297:Male; D008540:Meiosis / Q000502:physiology*; D009865:Oocytes / Q000502:physiology*; D011446:Prospective Studies; D020554:Sperm Injections, Intracytoplasmic / Q000379:methods*
D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone